Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. labmaster lucia

LABMASTER LUCIA

Labmaster Lucia - revolutionizing blood diagnostics with rapid accurate low-cost point-of-care tests

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 LABMASTER LUCIA project word cloud

Explore the words cloud of the LABMASTER LUCIA project. It provides you a very rough idea of what is the project "LABMASTER LUCIA" about.

blood    six    mobile    2kg    scientific    fast    commercialisation    16    targetted    limited    device    care    signal    laboratory    prescription    interference    fi    generating    ivd    simultaneous    cartridge    labmaster    disturbance    poc    immobile    hydrated    generation    instruments    diagnostics    health    patient    sold    point    asia    precision    public    compact    spending    antibodies    created    accurate    asian    media    speed    revenue    291m    anywhere    hospitals    1985    instrument    medium    medtech    segment    cartridges    oy    medical    below    reduce    10m    priced    innovations    diagnostic    expensive    hot    expert    sell    distributor    50    miniaturize    site    improves    bypass    cecl    23    patented    fraction    cathodic    antibiotic    hard    fluid    electrons    finland    ranges    critical    overcomes    creation    prepare    aecl    electrochemiluminescence    leader    lessen    small    slow    harnesses    2023    tests    commercialized    costly    vitro    breakthrough    staff    lucia    treatment    perform    minutes    options    clinics    17    distributors    secured    founded   

Project "LABMASTER LUCIA" data sheet

The following table provides information about the project.

Coordinator		 LABMASTER OY 

Organization address
address: FISKARSINKATU 11
city: TURKU
postcode: 20750
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Finland [FI]
 Project website http://labmaster.fi/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-02-01   to  2018-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LABMASTER OY FI (TURKU) coordinator 50˙000.00

Map

 Project objective

The Labmaster Lucia is the next generation diagnostics instrument for point-of-care blood tests. The compact device harnesses the breakthrough Cathodic ElectroChemiLuminescence (CECL) method to increase diagnostic speed and precision. Using the Lucia, medical staff can perform in vitro diagnostics (IVD) anywhere and get accurate results within five minutes at a fraction of the cost of existing methods. Blood diagnostics are critical for patient treatment, but current options are slow and costly due to large IVD immobile equipment. IVD devices are hard to miniaturize due to the scientific problem of sample medium signal interference. Labmaster's patented CECL technology overcomes signal disturbance problems using hydrated hot electrons that bypass fluid media, enabling the creation of small, mobile IVD devices for fast on-site diagnostics. Using CECL, Labmaster has created two products: (1) The Lucia, a 2kg POC IVD unit; (2) Test cartridges with antibodies to test a range of medical conditions. The Lucia improves on current FI and AECL IVD methods which require large expensive laboratory equipment, or have limited testing ranges. The Lucia has a wider testing range and allows simultaneous tests on one cartridge. It will be priced 50% below the current segment leader. This will reduce public health spending, improve treatment and lessen antibiotic prescription. The Lucia and cartridges will be sold to hospitals and clinics in Europe and Asia via medtech distributors. One Asian distributor is secured, six more will be targetted in this project. Labmaster Oy was founded in Finland in 1985, has 17 expert staff, and already commercialized 16 diagnostic innovations. It aims to sell 23,000 Lucia instruments and 10M cartridges by 2023, generating €291M in revenue. This project will prepare for the development of a new cartridge to test for a common condition, and prepare for commercialisation.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LABMASTER LUCIA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LABMASTER LUCIA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

JUMPAIR (2018)

Decubitus Ulcers Diseases Diagnoses by means of Smart ICT Anti-Decubitus System based on known Ulcers Activity Biomarkers

Read More  

ClearRing (2018)

An innovative, minimally invasive medical device used for treatment of Benign Prostatic Hyperplasia symptoms.

Read More